Drug Trial Radar · NCT05610280
A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia
Last checked: Nov 20, 2026Latest source record: Feb 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,478
Actual
Start
Nov 21, 2022
Primary completion
Aug 8, 2024
Study completion Jun 9, 2025
Sponsor
- Lead sponsor
- Ionis Pharmaceuticals, Inc.Ionis Pharmaceuticals (IONS)
- Sponsor type
- Industry
- First posted
- Nov 9, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to evaluate the effect of olezarsen on percent change in fasting triglyceride (TG) levels compared to placebo in participants with hypertriglyceridemia and atherosclerotic cardiovascular disease, or with severe hypertriglyceridemia.
Conditions
- Hypertriglyceridemia
- Cardiovascular Diseases
- Atherosclerosis
Interventions
OlezarsenDrug
Olezarsen will be administered by SC injection.
PlaceboDrug
Olezarsen-matching placebo will be administered by SC injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change From Baseline to Week 25 in Fasting Triglycerides (TG) Compared to PlaceboTime frame: Baseline to Week 25
Locations
168 sites in 14 countries. Site status is shown where the registry gives one.
Alabama Clinical Therapeutics, LLC Alabaster
Birmingham, Alabama
Heart Center Research PC
Huntsville, Alabama
Cardiovascular Research Foundation of Southern California
Beverly Hills, California
Westside Medical Associates of Los Angeles
Beverly Hills, California
Diabetes/Lipid Management & Research Center
Huntington Beach, California
University of California, San Diego (UCSD)
La Jolla, California
Clinical Trials Research
Lincoln, California
Amicis Research
Northridge, California
Valley Clinical Trials, Inc.
Northridge, California
Northern California Research
Sacramento, California
Amicis Research Center
Santa Clarita, California
Metabolic Institute of America
Tarzana, California
Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center
Torrance, California
Amicis Research Center
Valencia, California
Excel Clinical Medical Trials
Boca Raton, Florida
Finlay Medical Research - West Palm
Greenacres City, Florida
Global Research Associates
Homestead, Florida
3Sync Research
Lake Worth, Florida
Finlay Medical Research
Miami, Florida
Advanced Medical Research Institute (AMRI)
Miami, Florida
De La Cruz Research Center, LL
Miami, Florida
Suncoast Clinical Research, Inc. - New Port Richey
New Port Richey, Florida
Suncoast Clinical Research, Inc. - Palm Harbor
New Port Richey, Florida
Proactive Clinical Research
Oakland Park, Florida
Ocala Cardiovascular Research
Ocala, Florida
Comprehensive Medical & Research Center
Plantation, Florida
Progressive Medical Research
Port Orange, Florida
St. Johns Center for Clinical Research
Saint Augustine, Florida
JSV Clinical Research Study, Inc
Tampa, Florida
Centricity Research
Columbus, Georgia
Atlanta Heart Specialists
Tucker, Georgia
Evanston Premier Healthcare Research LLC
Evanston, Illinois
Clinical Investigation Specialists, Inc
Gurnee, Illinois
Affinity Health
Park Ridge, Illinois
Cardiovascular Research of Northwest Indiana, LLC
Munster, Indiana
Reid Hospital and Health Care Services
Richmond, Indiana
West Broadway Clinic
Council Bluffs, Iowa
Mercy One Iowa Heart Center
West Des Moines, Iowa
University of Kansas Medical Center (KUMC)
Kansas City, Kansas
Norton Cardiovascular Associates
Louisville, Kentucky
Showing 40 of 168 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.